Home | Welcome to Contract Pharma   
Last Updated Thursday, December 18 2014

Print RSS Feed

Search Results for 'Paladin, Apeiron in Neuroblastoma Pact'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

By Mr. Deepak Bahri, President
Published January 17, 2013
Paladin granted rights to market APN311 in Canada and Africa Read More »
By Tom Patnaik, Director of Sales & MArketing
By Anna Shagako, Clinical Operations Head
By Bob Muschert, Global Sales & Business Development Director
By Rob Chaney
By WITec GmbH

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On